Earnings

CNS Pharmaceuticals Q2 EPS $(0.38) Misses $(0.24) Estimate

Aug 12, 2026 · 08:03 AM ET· updated 1h ago

CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.24) by 58.33 percent. This is a 94.08 percent increase over losses of $(6.42) per share

Why It Matters

CNS Pharmaceuticals lost more money per share than experts thought it would. When a company loses money faster than people predicted, it can make investors wonder if the business plan is working out.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

CNSP5.25

-0.25 (-4.63%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.